Publication | Closed Access

Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer

UrologyRadiation MedicineRadiation TherapyMedicineSelect MenFailure-free SurvivalProstatic DiseaseOncologyRadiation OncologyIntermediate-risk Prostate Cancer